U.S. drug giant Pfizer and Germany’s BioNTech say their COVID-19 vaccine worked on more than 90 percent of people during a mass clinical trial.
It’s one of a dozen vaccines in the final stages of testing, raising hopes of an end to the pandemic.
However, scientists are urging caution.
How significant is this development?
Presenter: Mohammed Jamjoom
Oscar Alleyne – Epidemiologist and Chief of Programs and Services, National Association of County and City Health Officials
Gian Gandhi – UNICEF Coordinator for COVID-19 vaccine work
Ali Fattom – Vaccinologist and Vice President of Vaccine Research and Development, BlueWillow Biologics.
– Subscribe to our channel: http://aje.io/AJSubscribe
– Follow us on Twitter: https://twitter.com/AJEnglish
– Find us on Facebook: https://www.facebook.com/aljazeera
– Check our website: https://www.aljazeera.com/
#AlJazeeraEnglish #InsideStory #COVID19